FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   JOHNSON & JOHNSON 2. Date of Event Requiring Statement (Month/Day/Year) 03/27/2007 3. Issuer Name and Ticker or Trading Symbol eXegenics Inc [EXEG] (Last) (First) (Middle) ONE JOHNSON & JOHNSON PLAZA 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) NEW BRUNSWICK, NJ 08933 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series C Preferred Stock	03/27/2007	  (2)	Common Stock	12,973,600	$ 0	I	By Johnson & Johnson Development Corporation (1)
Warrants to Purchase Common Stock	03/27/2007	09/24/2014	Common Stock	810,849	$ 0.0193	I	By Johnson & Johnson Development Corporation (1)
Warrants to Purchase Common Stock	03/27/2007	07/01/2015	Common Stock	810,848	$ 0.0193	I	By Johnson & Johnson Development Corporation (1)
Warrants to Purchase Common Stock	03/27/2007	03/27/2017	Common Stock	265,489	$ 0.6728	I	By Johnson & Johnson Development Corporation (1)
Warrants to Purchase Common Stock	03/27/2007	03/27/2017	Common Stock	265,489	$ 0.8473	I	By Johnson & Johnson Development Corporation (1)
Warrants to Purchase Common Stock	03/27/2007	03/27/2017	Common Stock	265,489	$ 1.0466	I	By Johnson & Johnson Development Corporation (1)
Stock Options (Right to Buy)	03/27/2007	09/27/2007	Common Stock	5,189	$ 0.04	I	by Johnson & Johnson Development Corporation (1)
Stock Options (Right to Buy)	03/27/2007	09/27/2007	Common Stock	25,947	$ 0.04	I	by Johnson & Johnson Development Corporation (1)
Stock Options (Right to Buy)	03/27/2007	09/27/2007	Common Stock	103,788	$ 0.04	I	by Johnson & Johnson Development Corporation (1)
Stock Options (Right to Buy)	  (3)	09/27/2007	Common Stock	5,189	$ 0.04	I	by Johnson & Johnson Development Corporation (1)
Stock Options (Right to Buy)	  (4)	09/27/2007	Common Stock	155,682	$ 0.04	I	by Johnson & Johnson Development Corporation (1)

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NJ 08933	Â	  X	Â	Â

Signatures

Douglas Chia, Assistant Secretary		04/06/2007
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person.
(2)	There is no expiration date applicable to the Series C Preferred Stock.
(3)	As of 3/27/07 vested as to 2,810 shares.
(4)	As of 3/27/07 vested as to 56,218 shares.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.